Literature DB >> 23683347

Two-in-One antibodies with dual action Fabs.

Charles Eigenbrot1, Germaine Fuh.   

Abstract

Mechanisms and biological roles of antibody multi-specificity are topics of high interest. Evidence of conformational flexibility in antigen-combining sites and their utility in the recognition of different antigens appeared two decades ago. In the last three years an appreciation has emerged that recognition of very much more diverse protein antigens is within the scope of multi-specificity and also that this is sometimes, but not always, associated with structural plasticity. The ability to invent non-promiscuous, high affinity antibodies which are 'specific' for more than one antigen such as the recently described dual-specific Two-in-One DAF antibodies, provides not only insights into the evolution of antibody specificity but also a promise of powerful medicines fully within the paradigm of targeted therapies.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2013        PMID: 23683347     DOI: 10.1016/j.cbpa.2013.04.015

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  12 in total

Review 1.  Bispecific antibodies in cancer immunotherapy.

Authors:  Siqi Chen; Jing Li; Qing Li; Zhong Wang
Journal:  Hum Vaccin Immunother       Date:  2016-06-01       Impact factor: 3.452

2.  In vitro evolution of antibody affinity via insertional scanning mutagenesis of an entire antibody variable region.

Authors:  Kalliopi Skamaki; Stephane Emond; Matthieu Chodorge; John Andrews; D Gareth Rees; Daniel Cannon; Bojana Popovic; Andrew Buchanan; Ralph R Minter; Florian Hollfelder
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-16       Impact factor: 11.205

3.  A two-in-one antibody engineered from a humanized interleukin 4 antibody through mutation in heavy chain complementarity-determining regions.

Authors:  Chingwei V Lee; Patrick Koenig; Germaine Fuh
Journal:  MAbs       Date:  2014-03-11       Impact factor: 5.857

4.  A Generic Strategy to Generate Bifunctional Two-in-One Antibodies by Chicken Immunization.

Authors:  Julia Harwardt; Jan P Bogen; Stefania C Carrara; Michael Ulitzka; Julius Grzeschik; Björn Hock; Harald Kolmar
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

Review 5.  Protein purification and analysis: next generation Western blotting techniques.

Authors:  Manish Mishra; Shuchita Tiwari; Aldrin V Gomes
Journal:  Expert Rev Proteomics       Date:  2017-10-13       Impact factor: 3.940

6.  A dual-targeting triplebody mediates preferential redirected lysis of antigen double-positive over single-positive leukemic cells.

Authors:  Ingo Schubert; Domenica Saul; Stefanie Nowecki; Andreas Mackensen; Georg H Fey; Fuat S Oduncu
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

Review 7.  Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics.

Authors:  Heliang Li; Phei Er Saw; Erwei Song
Journal:  Cell Mol Immunol       Date:  2020-04-20       Impact factor: 11.530

8.  Bispecific Antibody Conjugated Manganese-Based Magnetic Engineered Iron Oxide for Imaging of HER2/neu- and EGFR-Expressing Tumors.

Authors:  Shou-Cheng Wu; Yu-Jen Chen; Hsiang-Ching Wang; Min-Yuan Chou; Teng-Yuan Chang; Shyng-Shiou Yuan; Chiao-Yun Chen; Ming-Feng Hou; John Tsu-An Hsu; Yun-Ming Wang
Journal:  Theranostics       Date:  2016-01-01       Impact factor: 11.556

Review 9.  Bispecific antibodies and their applications.

Authors:  Gaowei Fan; Zujian Wang; Mingju Hao; Jinming Li
Journal:  J Hematol Oncol       Date:  2015-12-21       Impact factor: 17.388

Review 10.  Current progress in innovative engineered antibodies.

Authors:  William R Strohl
Journal:  Protein Cell       Date:  2017-08-18       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.